Search

Author/Creator Elsten, Elisabeth M. P.

1. First‐Line Palliative HER2‐Targeted Therapy in HER2‐Positive Metastatic Breast Cancer Is Less Effective After Previous Adjuvant Trastuzumab‐Based Therapy. (22nd May 2017)

Authors:
Rier, Hánah N.; Levin, Mark‐David; van Rosmalen, Joost; Bos, Monique M. E. M.; Drooger, Jan C.; de Jong, Paul; Portielje, Johanneke E. A.; Elsten, Elisabeth M. P.; Ten Tije, Albert‐Jan; Sleijfer, Stefan; Jager, Agnes
Journal:
Oncologist
Issue:
Volume 22:Number 8(2017)
Page Start:
901
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. First‐Line Palliative HER2‐Targeted Therapy in HER2‐Positive Metastatic Breast Cancer Is Less Effective After Previous Adjuvant Trastuzumab‐Based Therapy. (August 2017)

Authors:
Rier, Hánah N.; Levin, Mark‐David; van Rosmalen, Joost; Bos, Monique M. E. M.; Drooger, Jan C.; de Jong, Paul; Portielje, Johanneke E. A.; Elsten, Elisabeth M. P.; Ten Tije, Albert‐Jan; Sleijfer, Stefan; Jager, Agnes
Journal:
Oncologist
Issue:
Volume 22:Number 8(2017)
Page Start:
901
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search